S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Realaus laiko atnaujinimai Bioqual, Inc. [BIOQ]

Birža: OTC Sektorius: Healthcare Pramonė: Diagnostics & Research
Atnaujinta30 bal. 2024 @ 19:10

0.00% $ 72.50

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 19:10):

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer...

Stats
Šios dienos apimtis 100.00
Vidutinė apimtis 25.00
Rinkos kapitalizacija 64.80M
EPS $0 ( 2024-04-22 )
Last Dividend $0.500 ( 2023-10-05 )
Next Dividend $0 ( N/A )
P/E 11.80
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2011-10-14 Williams Frank E Jr Sell 0 Bioqual
INSIDER POWER
0.00
Last 1 transactions
Buy: 0 | Sell: 0

Bioqual, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Bioqual, Inc. Finansinės ataskaitos

Annual 2022
Pajamos: $62.66M
Bruto pelnas: $8.64M (13.80 %)
EPS: $0.930
FY 2022
Pajamos: $62.66M
Bruto pelnas: $8.64M (13.80 %)
EPS: $0.930
FY 2018
Pajamos: $35.88M
Bruto pelnas: $8.73M (24.31 %)
EPS: $4.10
FY 2017
Pajamos: $36.60M
Bruto pelnas: $9.90M (27.06 %)
EPS: $4.44

Financial Reports:

No articles found.

Bioqual, Inc. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$1.000
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0.500
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Bioqual, Inc. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.38 - good (93.80%) | Divividend Growth Potential Score: 4.38 - Stable (12.44%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0700 2004-09-02
Last Dividend $0.500 2023-10-05
Next Dividend $0 N/A
Payout Date 2023-10-27
Next Payout Date N/A
# dividends 19 --
Total Paid Out $7.96 --
Avg. Dividend % Per Year 0.00% --
Score 2.75 --
Div. Sustainability Score 9.38
Div.Growth Potential Score 4.38
Div. Directional Score 6.88 --
Next Divdend (Est)
(2024-10-28)
$0.448 Estimate 3.08 %
Dividend Stability
0.25 Very Poor
Dividend Score
2.75
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
MTUAY Ex Dividend Junior 2023-05-12 Annually 0 0.00%
CNLHO Ex Dividend Knight 2023-07-07 Quarterly 0 0.00%
SYIEY Ex Dividend Knight 2023-05-11 Annually 0 0.00%
HKUOF Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
ANIOY Ex Dividend Junior 2023-07-13 Annually 0 0.00%
OSAGY No Dividend Player 2023-06-16 Annually 0 0.00%
DAIUF Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
TXHPF Ex Dividend Knight 2023-12-28 Semi-Annually 0 0.00%
JARLF Ex Dividend Knight 2023-08-17 Semi-Annually 0 0.00%
BDVSY Ex Dividend Junior 2023-09-28 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.01521.5009.7010.00[0 - 0.5]
returnOnAssetsTTM0.01631.2009.4610.00[0 - 0.3]
returnOnEquityTTM0.02491.500-0.834-1.251[0.1 - 1]
payoutRatioTTM0.467-1.0005.33-5.33[0 - 1]
currentRatioTTM4.220.80010.008.00[1 - 3]
quickRatioTTM4.020.80010.008.00[0.8 - 2.5]
cashRatioTTM1.5731.5002.373.55[0.2 - 2]
debtRatioTTM0.0600-1.5009.00-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM10.202.006.6010.00[0 - 30]
freeCashFlowPerShareTTM8.872.005.5710.00[0 - 20]
debtEquityRatioTTM0.0910-1.5009.64-10.00[0 - 2.5]
grossProfitMarginTTM0.1411.000-0.978-0.978[0.2 - 0.8]
operatingProfitMarginTTM0.01451.000-1.711-1.711[0.1 - 0.6]
cashFlowToDebtRatioTTM2.581.00010.0010.00[0.2 - 2]
assetTurnoverTTM1.0680.8006.214.97[0.5 - 2]
Total Score9.38

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM67.761.0003.260[1 - 100]
returnOnEquityTTM0.02492.50-0.536-1.251[0.1 - 1.5]
freeCashFlowPerShareTTM8.872.007.0410.00[0 - 30]
dividendYielPercentageTTM0.6901.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM10.202.006.6010.00[0 - 30]
payoutRatioTTM0.4671.5005.33-5.33[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1451.0008.870[0.1 - 0.5]
Total Score4.38

Bioqual, Inc.

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.